Skip to content

IDEXX Laboratories Inc

US · IDXX #543 by market cap Listed 1970
676.21 -13.44 -1.95%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • IDEXX Laboratories Inc(IDXX.US) Officer Sells US$17.68 Million in Common Stock
    Market Newswire · 2026/11/6
  • Company notice
    IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer Underberg Sharon E.
    SEC · 2026/11/6
  • Company notice
    IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer FENNELL GEORGE
    SEC · 2026/11/13
  • A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $700 to $810
    Market Newswire · 2026/11/4
  • Rating change
    KeyBanc Initiates IDEXX Laboratories Inc(IDXX.US) With Hold Rating
    Market Newswire · 2026/10/12
  • Form 144 | IDEXX Laboratories Inc(IDXX.US) Officer Proposes to Sell 6.13 Million in Common Stocks
    Market Newswire · 2026/11/5
  • Rating change
    UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $670
    Market Newswire · 2026/9/16
  • Company notice
    IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer MAZELSKY JONATHAN JAY
    SEC · 2026/11/19
  • Rating change
    UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $700
    Market Newswire · 2026/11/3
  • Company notice
    IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Director JUNIUS DANIEL M
    SEC · 2026/11/6
  • Rating change
    William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating
    Market Newswire · 2026/10/2
  • Rating change
    Analysts Conflicted on These NA Names: Rapport Therapeutics, Inc. (RAPP), Idexx Laboratories (IDXX) and Waystar Holding Corp. (WAY)
    TipRanks · 2026/9/16
  • Rating change
    Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $675
    Market Newswire · 2026/8/14
  • Rating change
    BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $665
    Market Newswire · 2026/8/14
  • Rating change
    J.P. Morgan Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $750
    Market Newswire · 2026/10/16
  • Rating change
    Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $805
    Market Newswire · 2026/11/3
  • Company notice
    IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer Lane Michael
    SEC · 2026/11/21
  • Rating change
    UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $627
    Market Newswire · 2026/10/27
  • IDEXX Laboratories Inc(IDXX.US) Officer Sells US$6.13 Million in Common Stock
    Market Newswire · 2026/11/6
  • Form 144 | IDEXX Laboratories Inc(IDXX.US) Officer Proposes to Sell 17.68 Million in Common Stocks
    Market Newswire · 2026/11/5
  • Company notice
    IDEXX Laboratories Inc | 144/A: Others
    SEC · 2026/11/6
  • Company notice
    IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer MAZELSKY JONATHAN JAY
    SEC · 2026/11/6
  • Company notice
    IDEXX Laboratories Inc | 4: Statement of changes in beneficial ownership of securities-Officer Lane Michael
    SEC · 2026/11/6
  • Rating change
    Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670
    Market Newswire · 2026/8/5
  • Rating change
    BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $660
    Market Newswire · 2026/7/8

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.

IDEXX Laboratories Inc discussion 0 comments

Add a comment